Profil
Xiaoqi Liu is currently the Director & Business Development at Formation Bio Inc since 2023.
Prior to this, he worked as Director & Business Development at Halozyme Therapeutics, Inc. from 2021 to 2022 and as Director, Strategy & Corporate Development at Gelesis, Inc. from 2020 to 2021.
Liu completed his graduate degree at Northwestern University and his undergraduate degree at Beijing Normal University.
Postes actifs de Xiaoqi Liu
| Sociétés | Poste | Début |
|---|---|---|
Trialspark, Inc.
Trialspark, Inc. BiotechnologyHealth Technology Operates as a pharma company that engages in the development of drugs and treatments | Corporate Officer/Principal | 01/01/2023 |
Anciens postes connus de Xiaoqi Liu
| Sociétés | Poste | Fin |
|---|---|---|
| HALOZYME THERAPEUTICS, INC. | Corporate Officer/Principal | 01/12/2022 |
| GELESIS INC | Corporate Officer/Principal | 01/12/2021 |
Formation de Xiaoqi Liu
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 5 |
|---|---|
Halozyme Therapeutics, Inc.
Halozyme Therapeutics, Inc. BiotechnologyHealth Technology Engages in the development and commercialization of recombinant human enzymes for the infertility, ophthalmology & oncology markets | Health Technology |
Gelesis, Inc.
Gelesis, Inc. BiotechnologyHealth Technology Operates as biotechnology company which develops novel category of therapies for GI-related chronic diseases | Health Technology |
Northwestern University
Northwestern University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Beijing Normal University
Beijing Normal University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Trialspark, Inc.
Trialspark, Inc. BiotechnologyHealth Technology Operates as a pharma company that engages in the development of drugs and treatments | Health Technology |
















